ProfileGDS4459 / ENSG00000065029
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 40% 57% 46% 27% 34% 40% 50% 43% 40% 46% 38% 45% 53% 22% 53% 29% 24% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.1140
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.6457
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.246
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.7427
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.7834
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.0440
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.4450
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.0743
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.9640
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.2946
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.8838
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.1445
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.5353
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.5122
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.4953
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.7229
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.5224